Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 17, 2026, titled "Zydus launches PEPAIR, a first in India, affordable, drug-free, handheld device for better respiratory health".
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences has announced the launch of PEPAIR, a first-in-India, affordable, drug-free, handheld device designed to improve respiratory health. The product is positioned as accessible and non-pharmaceutical, targeting a mass-market audience. This represents a diversification move for Zydus into the medical devices and respiratory care segment, an area with significant demand in India. No financial figures or pricing details were disclosed in the press release filing.
This launch strengthens Zydus's presence in the consumer healthcare and medical devices space, potentially opening a new revenue stream. For shareholders, it signals portfolio expansion beyond traditional pharma, though near-term financial impact is unclear without pricing and volume details.